Local_NP Character_NP of_IN Readthrough_NP Activation_NP in_IN Adenovirus_NP Type_NP 5_CD Early_RB Region_NP 1_CD Transcription_NP Control_NP Wild-type_NP early_JJ activity_NN of_IN the_DT adenovirus_NN 5_CD E1b_NP gene_NN promoter_NN requires_VBZ readthrough_JJ transcription_NN originating_VBG from_IN the_DT adjacent_JJ upstream_JJ E1a_NP gene_NN ._SENT This_DT unusual_JJ mode_NN of_IN viral_JJ transcription_NN activation_NN was_VBD identified_VBN by_IN genetic_JJ manipulation_NN of_IN the_DT mouse_NN betamaj-globin_NN gene_NN transcription_NN termination_NN sequence_NN (_( GGT_NP )_) inserted_VBD into_IN the_DT E1a_NP gene_NN ._SENT To_TO facilitate_VB further_JJR study_NN of_IN the_DT mechanism_NN of_IN readthrough_JJ activation_NN ,_, the_DT activities_NNS of_IN GGT_NP and_CC a_DT composite_JJ termination_NN sequence_NN CT_NP were_VBD tested_VBN in_IN recombinant_JJ adenoviruses_NNS containing_VBG luciferase_NN reporters_NNS driven_VBN by_IN the_DT E1b_NP promoter_NN ._SENT There_EX was_VBD a_DT strict_JJ correlation_NN between_IN readthrough_NN and_CC substantial_JJ downstream_JJ gene_NN expression_NN ,_, indicating_VBG that_DT interference_NN with_IN downstream_JJ transcription_NN was_VBD not_RB a_DT unique_JJ property_NN of_IN GGT_NP ._SENT Blockage_NN of_IN readthrough_JJ transcription_NN of_IN E1a_NP had_VBD no_DT apparent_JJ effect_NN on_IN early_JJ expression_NN of_IN the_DT major_JJ late_JJ promoter_NN ,_, the_DT next_JJ active_JJ promoter_NN downstream_JJ of_IN E1b_NP ._SENT A_DT test_NN for_IN epistatic_JJ interaction_NN between_IN termination_NN sequence_NN insertions_NNS and_CC E1a_NP enhancer_NN mutations_NNS suggested_VBD that_IN readthrough_JJ activation_NN and_CC E1a_NP enhancer_NN activation_NN of_IN the_DT E1b_NP promoter_NN are_VBP mechanistically_RB distinct_JJ ._SENT In_IN addition_NN ,_, substitution_NN of_IN the_DT human_JJ cytomegalovirus_NN major_JJ immediate-early_JJ promoter_NN for_IN the_DT E1b_NP promoter_NN suppressed_VBD the_DT requirement_NN for_IN readthrough_NN ._SENT These_DT results_NNS suggest_VBP that_IN readthrough_NN activation_NN is_VBZ a_DT "_`` local_JJ "_'' effect_NN of_IN a_DT direct_JJ interaction_NN between_IN the_DT invading_VBG transcription_NN elongation_NN complex_NN and_CC the_DT E1b_NP promoter_NN ._SENT DNase_NP I_NP hypersensitivity_NN footprinting_NN provided_VBD evidence_NN that_IN this_DT interaction_NN altered_VBD an_DT extensive_JJ E1b_NP promoter_NN DNA-protein_NP complex_NN that_WDT was_VBD assembled_VBN in_IN the_DT absence_NN of_IN readthrough_JJ transcription_NN ._SENT In_IN cells_NNS infected_VBN with_IN adenovirus_NN type_NN 5_CD ,_, transcription_NN from_IN the_DT E1a_NP promoter_NN does_VBZ not_RB terminate_VB upstream_RB of_IN the_DT adjacent_JJ E1b_NP gene_NN promoter_NN ._SENT Instead_RB ,_, the_DT E1a_NP transcripts_NNS usually_RB are_VBP elongated_VBN through_IN the_DT E1b_NP promoter_NN and_CC invade_VB the_DT E1b_NP gene_NN coding_VBG region_NN ._SENT Artificial_JJ termination_NN of_IN this_DT readthrough_JJ transcription_NN by_IN insertion_NN of_IN the_DT mouse_NN beta-major_NN globin_NN terminator_NN (_( GGT_NP )_) dramatically_RB reduces_VBZ early_JJ ,_, but_CC not_RB late_RB ,_, E1b_NP gene_NN expression_NN ._SENT The_DT simplest_JJS interpretation_NN of_IN this_DT result_NN is_VBZ that_IN readthrough_NN transcription_NN is_VBZ required_VBN for_IN wild-type_NN (_( wt_NN )_) activity_NN of_IN the_DT E1b_NP promoter_NN early_RB after_IN infection_NN ._SENT Strong_JJ evidence_NN for_IN this_DT unusual_JJ mode_NN of_IN gene_NN regulation_NN was_VBD provided_VBN by_IN the_DT observation_NN that_IN base_JJ substitution_NN mutations_NNS in_IN GGT_NP that_IN specifically_RB relieve_VB transcription_NN termination_NN restore_VB early_JJ E1b_NP promoter_NN activity_NN in_IN cis_NNS ._SENT This_DT result_NN indicated_VBD that_IN the_DT inhibition_NN caused_VBN by_IN GGT_NP arises_VBZ solely_RB from_IN the_DT transcription_NN termination_NN properties_NNS of_IN the_DT sequence_NN insertion_NN ._SENT This_DT stimulation_NN of_IN early_JJ E1b_NP transcription_NN was_VBD designated_VBN readthrough_JJ activation_NN ._SENT Initial_JJ attempts_NNS to_TO map_VB the_DT target_NN of_IN activation_NN to_TO particular_JJ E1b_NP promoter_NN elements_NNS by_IN assaying_VBG for_IN epistasis_NN between_IN insertion_NN of_IN GGT_NP and_CC promoter_NN mutations_NNS provided_VBD no_DT evidence_NN for_IN a_DT particular_JJ target_NN sequence_NN in_IN the_DT promoter_NN ._SENT These_DT findings_NNS raised_VBD the_DT possibility_NN that_IN readthrough_NN transcription_NN activates_VBZ the_DT E1b_NP promoter_NN by_IN a_DT mechanism_NN other_JJ than_IN by_IN direct_JJ recruitment_NN of_IN sequence-specific_JJ DNA_NN binding_VBG proteins_NNS to_TO the_DT promoter_NN ._SENT One_CD line_NN of_IN evidence_NN suggested_VBD that_IN a_DT global_JJ property_NN of_IN the_DT early_JJ template_NN could_MD be_VB involved_VBN ._SENT Despite_IN the_DT fact_NN that_IN the_DT relief_NN of_IN inhibition_NN by_IN GGT_NP occurs_VBZ after_IN the_DT onset_NN of_IN viral_JJ DNA_NN replication_NN ,_, the_DT requirement_NN for_IN readthrough_NN is_VBZ not_RB complemented_VBN in_IN trans_NNS when_WRB late-infected_JJ cells_NNS are_VBP superinfected_VBN with_IN templates_NNS whose_WP$ replication_NN is_VBZ prevented_VBN ._SENT This_DT result_NN suggests_VBZ that_IN the_DT readthrough_JJ requirement_NN is_VBZ a_DT cis-dominant_JJ property_NN of_IN the_DT early_JJ template_NN ._SENT Among_IN the_DT possibilities_NNS are_VBP transcription-driven_JJ template_NN remodeling_NN ,_, an_DT activity_NN of_IN the_DT E1a_NP enhancer_NN that_WDT mediates_VBZ cis-acting_JJ global_JJ stimulation_NN of_IN early_JJ viral_JJ gene_NN transcription_NN ,_, or_CC a_DT direct_JJ interaction_NN between_IN the_DT invading_VBG transcription_NN elongation_NN complex_NN and_CC a_DT prereplicative_JJ E1b_NP promoter_NN complex_NN ._SENT We_PP report_VBP here_RB the_DT results_NNS of_IN experiments_NNS that_WDT were_VBD designed_VBN to_TO investigate_VB further_RBR the_DT nature_NN of_IN readthrough_JJ activation_NN ._SENT To_TO validate_VB a_DT stringent_JJ connection_NN between_IN readthrough_JJ transcription_NN and_CC activation_NN of_IN the_DT early_JJ E1b_NP promoter_NN ,_, we_PP tested_VBD whether_IN a_DT different_JJ transcription_NN termination_NN sequence_NN also_RB inhibited_VBD early_JJ E1b_NP transcription_NN ._SENT A_DT second_JJ set_NN of_IN experiments_NNS examined_VBD the_DT relationship_NN between_IN readthrough_NN and_CC certain_JJ global_JJ aspects_NNS of_IN early_JJ viral_JJ transcription_NN control_NN ._SENT Several_JJ lines_NNS of_IN evidence_NN implicated_VBN a_DT "_`` local_JJ "_'' rather_RB than_IN a_DT global_JJ mechanism_NN for_IN readthrough_JJ activation_NN of_IN early_JJ E1b_NP gene_NN expression_NN ._SENT Consistent_JJ with_IN this_DT notion_NN ,_, preventing_VBG readthrough_NN produced_VBD a_DT slightly_RB altered_VBN pattern_NN of_IN DNase_NP I_NP hypersensitivity_NN of_IN the_DT E1b_NP promoter_NN in_IN early-infected_JJ cells_NNS ,_, suggesting_VBG that_IN the_DT interaction_NN affected_VBD the_DT structure_NN or_CC composition_NN of_IN the_DT promoter-protein_NN complexes_NNS ._SENT Cells_NNS and_CC viruses_NNS ._SENT |_SYM Monolayers_NP of_IN HeLa_NP cells_NNS or_CC 293_CD cells_NNS were_VBD maintained_VBN as_IN described_VBN previously_RB ._SENT Adenovirus_NN stocks_NNS were_VBD prepared_VBN from_IN infected_JJ monolayers_NNS of_IN 293_CD cells_NNS as_IN cell_NN lysates_NNS or_CC purified_VBN by_IN two_CD rounds_NNS of_IN density_NN gradient_JJ centrifugation_NN ._SENT Virus_NN stocks_NNS were_VBD quantified_VBN by_IN plaque_NN titration_NN on_IN monolayer_NN cultures_NNS of_IN 293_CD cells_NNS ._SENT The_DT origins_NNS of_IN wt_JJ adenovirus_NN type_NN 5_CD ,_, dl309_NP ,_, dl2004_NN ,_, and_CC recombinant_JJ strains_NNS in2011_JJ ,_, sub2040_JJ ,_, sub2041_JJ ,_, sub2046_JJ ,_, and_CC sub2047_JJ have_VBP been_VBN described_VBN previously_RB ._SENT The_DT sub2040_JJ series_NN strains_NNS contain_VBP the_DT dl343_JJ E1a_NP chain-termination_NN mutation_NN ,_, a_DT chloramphenicol_NN acetyltransferase_NN (_( CAT_NP )_) reporter_NN gene_NN in_IN place_NN of_IN the_DT E1b_NP coding_VBG region_NN ,_, and_CC ,_, except_IN for_IN sub2046_NN ,_, a_DT termination_NN sequence_NN insertion_NN ._SENT Recombinant_JJ DNA_NN ._SENT |_SYM A_DT double-stranded_JJ oligonucleotide_NN containing_VBG the_DT AT-rich_NP transcription_NN termination_NN sequence_NN from_IN the_DT human_JJ gastrin_NN gene_NN (_( GaT_NP )_) and_CC four_CD unpaired_JJ bases_NNS at_IN each_DT end_NN for_IN ligation_NN to_TO an_DT NcoI_NP site_NN was_VBD produced_VBN by_IN annealing_VBG the_DT synthetic_JJ oligonucleotides_NN 5'-CATGGTTTTTTTTTAATTTTTATTTTATTTTATTTTT-3_NN '_'' and_CC 5'-CATGAAAAATAAAATAAAATAAAAATTAAAAAAAAAC-3_NP '_'' (_( Hershey_NP Medical_NP Center_NP Core_NP Facility_NP )_) ._SENT The_DT double-stranded_JJ oligonucleotide_NN was_VBD inserted_VBN into_IN the_DT SmaI_NP site_NN of_IN pBLSK+_NN (_( Stratagene_NP )_) in_IN either_DT orientation_NN to_TO produce_VB pBLGT_NN ._SENT A_DT 313-bp_JJ BstYI_NP DNA_NP fragment_NN containing_VBG the_DT wt_NN (_( pA_NN )_) or_CC mutated_VBN (_( pA_NN "_'' )_) form_NN of_IN the_DT 5_CD '_POS end_NN of_IN the_DT mouse_NN betamaj-globin_NN gene_NN transcription_NN termination_NN sequence_NN was_VBD inserted_VBN into_IN the_DT BamHI_NP site_NN of_IN pBLGT_NN ,_, and_CC the_DT clones_NNS were_VBD screened_VBN for_IN orientation_NN ._SENT Plasmids_NNS with_IN the_DT BstYI_NP DNA_NP fragment_NN upstream_RB of_IN the_DT AT-rich_NP sequence_NN were_VBD designated_VBN pCT_NN (_( composite_JJ terminator_NN )_) and_CC pCTdpm_NN (_( double_JJ point_NN mutations_NNS [_SYM see_VB reference_NN ]_SYM )_) ,_, and_CC the_DT inserts_NNS were_VBD designated_VBN pAGaT_NN and_CC pA"GaT_NN ,_, respectively_RB ._SENT Plasmids_NNS for_IN strains_NNS containing_VBG a_DT luciferase_NN reporter_NN gene_NN were_VBD constructed_VBN from_IN cloning_VBG vector_NN pACCMVpLpA_NN (_( obtained_VBN from_IN Alex_NP F._NP Y._NP Chen_NP ,_, Mayo_NP Clinic_NP )_) ._SENT This_DT plasmid_NN contains_VBZ an_DT expression_NN cassette_NN with_IN adenovirus_NN nucleotides_NNS (_( nt_NN )_) 1_CD to_TO 454_CD ,_, the_DT major_JJ immediate-early_JJ promoter_NN (_( MIEP_NP )_) of_IN human_JJ cytomegalovirus_NN ,_, a_DT polylinker_NN cloning_VBG site_NN ,_, the_DT simian_JJ virus_NN 40_CD poly(A)_NN site_NN ,_, and_CC adenovirus_NN nt_NN 3334_CD to_TO 6231_CD ._SENT The_DT NotI_NP site_NN at_IN the_DT junction_NN of_IN the_DT simian_JJ virus_NN 40_CD poly(A)_NN sequence_NN and_CC adenovirus_NN nt_NN 3334_CD was_VBD inactivated_VBN by_IN partial_JJ digestion_NN with_IN NotI_NP ,_, repair_NN of_IN the_DT recessed_VBN 3_CD '_POS ends_NNS with_IN DNA_NN polymerase_NN I_PP (_( Klenow_NP )_) ,_, and_CC religation_NN ._SENT The_DT second_JJ NotI_NP site_NN is_VBZ located_VBN at_IN the_DT junction_NN of_IN adenovirus_NN nt_NNS 454_CD and_CC the_DT 5_CD '_POS end_NN of_IN the_DT MIEP_NP ._SENT An_DT NcoI-XbaI_NP DNA_NP fragment_NN containing_VBG the_DT luciferase_NN (_( Luc_NP )_) gene_NN from_IN pGL3_NN (_( Promega_NP )_) was_VBD inserted_VBN into_IN the_DT HindIII_NP site_NN in_IN the_DT polylinker_NN of_IN the_DT modified_JJ version_NN of_IN pACCMVpLpA_NN to_TO produce_VB pACMIEPLuc_NN ._SENT NcoI-XbaI_NP DNA_NP fragments_VBZ containing_VBG pAGaT_NN or_CC pA"GaT_NN were_VBD excised_VBN from_IN pCT_NN and_CC pCTdpm_NN ,_, respectively_RB ,_, and_CC inserted_VBN into_IN the_DT unique_JJ NotI_NP site_NN of_IN pACMIEPLuc_NN ._SENT After_IN screening_NN for_IN the_DT proper_JJ orientation_NN of_IN the_DT inserted_JJ DNA_NN ,_, plasmids_NNS were_VBD identified_VBN that_IN contained_VBN adenovirus_NN nt_NN 1_CD to_TO 454_CD ,_, a_DT copy_NN of_IN the_DT wt_NN or_CC mutated_VBN composite_JJ termination_NN sequence_NN ,_, and_CC an_DT MIEP-Luc_NP expression_NN unit_NN ._SENT Although_IN this_DT configuration_NN removes_VBZ the_DT E1a_NP TATA_NP box_NN and_CC major_JJ transcription_NN start_NN site_NN ,_, upstream_JJ initiation_NN is_VBZ expected_VBN to_TO supply_VB about_RB 20_CD %_NN of_IN the_DT normal_JJ rate_NN of_IN E1a_NP promoter_NN activity_NN in_IN infected_JJ cells_NNS ._SENT Accordingly_RB ,_, these_DT arrangements_NNS of_IN viral_JJ DNA_NN and_CC transcription_NN termination_NN sequences_NNS were_VBD designated_VBN exon_NN 1_CD insertions_NNS ._SENT These_DT two_CD plasmids_NNS ,_, pACCTMIEPLuc_NN and_CC pACCTdpmMIEPLuc_NN ,_, were_VBD the_DT source_NN of_IN virus_NN strains_NNS sub2020_JJ and_CC sub2021_JJ ._SENT The_DT MIEP_NP in_IN pACCTMIEPLuc_NN and_CC pACCTdpmMIEPLuc_NN was_VBD excised_VBN by_IN digestion_NN with_IN ClaI_NP and_CC SalI_NP and_CC replaced_VBN by_IN inserting_VBG a_DT 377-bp_JJ XbaI_NP DNA_NN fragment_NN from_IN p362CAT_NN that_WDT contains_VBZ the_DT E1b_NP promoter_NN ,_, including_VBG about_RB 360_CD bp_NN 5_CD '_'' of_IN the_DT transcription_NN initiation_NN site_NN ._SENT The_DT resulting_VBG plasmids_NNS ,_, pACCTE1bLuc_NN and_CC pACCTdpmE1bLuc_NN ,_, which_WDT contain_VBP an_DT E1b-Luc_NP expression_NN unit_NN ,_, were_VBD the_DT source_NN of_IN virus_NN strains_NNS sub2022_NN and_CC sub2023_NN ,_, respectively_RB ._SENT The_DT plasmid_NP pE1a-dl343_NN ,_, obtained_VBN from_IN P._NP Hearing_NP ,_, has_VBZ been_VBN described_VBN previously_RB ._SENT It_PP contains_VBZ the_DT dl343_JJ E1a_NP allele_NN ,_, which_WDT results_VBZ in_IN premature_JJ termination_NN of_IN translation_NN ._SENT p343/112_NN was_VBD constructed_VBN by_IN substituting_VBG adenovirus_NN nt_NN 1_CD to_TO 1009_CD (_( SmaI_NP site_NN )_) from_IN plasmid_NN pE1a-dl343_NN for_IN the_DT corresponding_JJ region_NN in_IN plasmid_NP pXC101_NP ,_, which_WDT includes_VBZ the_DT dl112_JJ E1b_NP allele_NN ._SENT The_DT region_NN containing_VBG the_DT termination_NN sequence_NN copy_NN ,_, MIEP-Luc_NP expression_NN unit_NN ,_, and_CC 3_CD '_'' adenovirus_NN DNA_NN sequences_NNS was_VBD excised_VBN with_IN BstXI_NP from_IN pACCTMIEPLuc_NN or_CC pACCTdpmMIEPLuc_NN and_CC joined_VBD to_TO a_DT XbaI-ClaI_NP DNA_NN fragment_NN from_IN p343/112_NN that_WDT contains_VBZ adenovirus_NN nt_NN 1_CD to_TO 1338_CD and_CC vector_NN sequences_NNS ._SENT The_DT resulting_VBG plasmids_NNS contained_VBD the_DT termination_NN sequence_NN inserted_VBN in_IN E1a_NP exon_NN 2_CD (_( position_NN 1338_CD )_) ._SENT These_DT two_CD plasmids_NNS ,_, pAC343CTMIEPLuc_NN and_CC pAC343CTdpmMIEPLuc_NN ,_, were_VBD the_DT source_NN of_IN virus_NN strains_NNS sub2026_JJ and_CC sub2027_JJ ,_, respectively_RB ._SENT A_DT similar_JJ strategy_NN was_VBD used_VBN to_TO isolate_VB plasmids_NNS pAC343CTE1bLuc_NN and_CC pAC343CTdpmE1bLuc_NN ,_, the_DT sources_NNS of_IN sub2024_NN and_CC sub2025_NN ,_, respectively_RB ._SENT Plasmid_NP pAC343E1bLuc_NP ,_, the_DT source_NN of_IN sub2100_NN ,_, was_VBD constructed_VBN by_IN exchanging_VBG an_DT EcoRI/BstXI_NP DNA_NN fragment_NN from_IN pACCTE1bLuc_NN ,_, which_WDT contains_VBZ the_DT E1b-Luc_NP gene_NN and_CC the_DT downstream_JJ adenovirus_NN sequences_NNS for_IN the_DT corresponding_JJ E1b_NP promoter_NN and_CC gene_NN sequences_NNS as_IN an_DT XbaI/SphI_NP DNA_NN fragment_NN of_IN p343/101_NN ._SENT The_DT resulting_VBG plasmid_NN contained_VBD the_DT dl343_JJ E1a_NP allele_NN and_CC the_DT E1b-Luc_NP expression_NN unit_NN ._SENT To_TO construct_VB plasmids_NNS with_IN exon_NN 2_CD insertions_NNS of_IN GGT_NP ,_, the_DT region_NN of_IN pXC1/t-CAT_NN or_CC pXC1/t(dpm)-CAT_NN containing_VBG the_DT GGT_NP copy_NN and_CC some_DT flanking_VBG adenovirus_NN sequences_NNS was_VBD excised_VBN with_IN ClaI_NP and_CC PshAI_NP and_CC substituted_VBN for_IN the_DT corresponding_JJ segment_NN of_IN pAC343CTE1bLuc_NN ._SENT The_DT resulting_VBG plasmids_NNS ,_, pAC343GGTE1bLuc_NN and_CC pAC343GGTdpmE1bLuc_NN ,_, were_VBD the_DT sources_NNS of_IN sub2028_NN and_CC sub2029_NN ,_, respectively_RB ._SENT A_DT similar_JJ strategy_NN was_VBD used_VBN to_TO construct_VB pAC343GGTMIEPLuc_NN and_CC pAC343GGTdpmMIEPLuc_NN ,_, the_DT sources_NNS of_IN sub2030_NN and_CC sub2031_JJ ,_, respectively_RB ,_, except_IN that_WDT the_DT replacement_NN in_IN pAC343CTMIEPLuc_NN was_VBD accomplished_VBN by_IN a_DT ClaI/ClaI_NP fragment_NN exchange_NN ._SENT The_DT plasmid_NP pterm112_NN has_VBZ been_VBN described_VBN elsewhere_RB ._SENT The_DT E1a_NP enhancer_NN region_NN was_VBD removed_VBN by_IN excising_VBG a_DT BsrGI-SacII_NP fragment_NN containing_VBG adenovirus_NN type_NN 5_CD nt_NN 196_CD to_TO 357_CD from_IN pterm112_NN to_TO produce_VB pterm112-2_NN ,_, the_DT source_NN of_IN in2011-2_NN ._SENT A_DT similar_JJ strategy_NN was_VBD used_VBN to_TO produce_VB plasmid_NN p343/112-2_NN ,_, the_DT source_NN of_IN dl340/112-2_NN ._SENT Recombinant_JJ viruses_NNS ._SENT |_SYM Recombinant_NP adenoviruses_NNS were_VBD constructed_VBN by_IN overlap_VB recombination_NN of_IN plasmids_NNS into_IN the_DT dl309_NN or_CC dl340_NN genome_NN as_RB described_VBD previously_RB ._SENT Structures_NNS of_IN recombinant_JJ viral_JJ genomes_NNS were_VBD determined_VBN by_IN restriction_NN enzyme_NN analysis_NN of_IN DNA_NN samples_NNS enriched_VBN for_IN viral_JJ DNA_NN by_IN a_DT modified_JJ Hirt_NP procedure_NN ._SENT Viral_JJ isolates_NNS were_VBD plaque_NN purified_VBN two_CD additional_JJ times_NNS prior_RB to_TO stock_NN preparation_NN ._SENT Recombinant_JJ adenoviruses_NNS containing_VBG luciferase_JJ reporter_NN genes_NNS were_VBD constructed_VBN in_IN a_DT dl309_JJ genetic_JJ background_NN (_( E3_NP variant_NN )_) from_IN the_DT plasmids_NNS described_VBD above_IN ._SENT Recombinant_JJ strains_NNS used_VBN for_IN the_DT analysis_NN of_IN genetic_JJ interaction_NN between_IN transcription_NN termination_NN and_CC the_DT E1a_NP enhancer_NN were_VBD constructed_VBN in_IN a_DT dl340_JJ background_NN ._SENT The_DT strain_NN in2011_NN ,_, originally_RB isolated_VBN in_IN a_DT dl309_JJ background_NN ,_, was_VBD reconstructed_VBN in_IN a_DT dl340_JJ background_NN for_IN the_DT purposes_NNS of_IN this_DT work_NN ._SENT RNA_NP analysis_NN ._SENT |_SYM HeLa_NP cells_NNS were_VBD coinfected_VBN with_IN 20_CD PFU_NP each_DT of_IN wt_JJ adenovirus_NN type_NN 5_CD and_CC a_DT test_NN strain_NN per_IN cell_NN ._SENT Cytoplasmic_JJ RNA_NP or_CC nuclear_JJ RNA_NP was_VBD harvested_VBN 4.25_CD h_NN postinfection_NN (_( hpi_NN )_) for_IN measurement_NN of_IN early_JJ gene_NN expression_NN ._SENT Cytoplasmic_JJ RNA_NP or_CC nuclear_JJ RNA_NP was_VBD prepared_VBN as_IN described_VBN previously_RB ,_, assayed_VBN by_IN hybridization_NN and_CC protection_NN from_IN digestion_NN by_IN nuclease_NN S1_NP ,_, and_CC quantified_VBD as_RB described_VBN previously_RB ._SENT All_DT hybridization_NN probes_NNS were_VBD prepared_VBN by_IN digestion_NN with_IN an_DT appropriate_JJ restriction_NN enzyme_NN ,_, labeling_VBG at_IN the_DT 5_CD '_POS end_NN with_IN T4_NP polynucleotide_NN kinase_NN and_CC [_SYM gamma-32P]ATP_NN ,_, and_CC digestion_NN with_IN a_DT second_JJ restriction_NN enzyme_NN prior_RB to_TO isolating_JJ DNA_NN fragments_NNS labeled_VBN at_IN one_CD 5_CD '_'' end_NN ._SENT To_TO detect_VB MIEP-Luc_NP RNA_NP ,_, a_DT 1,003-bp_JJ probe_NN was_VBD prepared_VBN as_IN a_DT ScaI_NP (_( labeled_VBN end)-HindIII_NN fragment_NN from_IN pACCTMIEPLuc_NN ._SENT To_TO detect_VB E1b-Luc_NP RNA_NP ,_, a_DT 580-bp_JJ probe_NN was_VBD prepared_VBN as_IN a_DT ScaI_NP (_( labeled_VBN end)-HindIII_NN fragment_NN from_IN pACCTE1bLuc_NN ._SENT To_TO detect_VB wt_NP E1b_NP RNA_NP ,_, we_PP used_VBD a_DT 713-bp_JJ probe_NN prepared_VBN as_IN a_DT KpnI_NP (_( labeled_VBN end)-XbaI_NN fragment_NN from_IN plasmid_NN pXC7_JJ ._SENT The_DT probe_NN for_IN detecting_VBG E3_NP transcription_NN was_VBD prepared_VBN as_IN described_VBN previously_RB ._SENT To_TO detect_VB E1a_NP transcription_NN downstream_RB of_IN the_DT transcription_NN termination_NN sequences_NNS in_IN MIEP-Luc_NP strains_NNS (_( readthrough_NN transcription_NN )_) ,_, a_DT 1,376-bp_JJ probe_NN was_VBD isolated_VBN as_IN an_DT NdeI_NP (_( labeled_VBN end)-ScaI_NN fragment_NN from_IN pACCMVpLpA_NN ._SENT To_TO detect_VB readthrough_JJ transcription_NN from_IN E1b-Luc_NP strains_NNS ,_, a_DT 1,215-bp_JJ probe_NN was_VBD prepared_VBN as_IN a_DT HpaI_NP (_( labeled_VBN end)-SacII_NN fragment_NN of_IN pXC1_NN ._SENT The_DT preparation_NN of_IN probes_NNS for_IN simultaneous_JJ detection_NN of_IN wt_NN and_CC dl112_JJ E1b_NP RNA_NP ,_, or_CC wt_NP and_CC dl309_NP E3_NP RNA_NP ,_, was_VBD described_VBN previously_RB ._SENT A_DT probe_NN for_IN detection_NN of_IN unspliced_JJ major_JJ late_JJ promoter_NN (_( MLP_NP )_) transcripts_NNS was_VBD prepared_VBN as_IN a_DT HindIII_NP (_( labeled_VBN end)-XhoI_NN fragment_NN from_IN plasmid_NN pHinC_NN ._SENT Band_NN intensities_NNS were_VBD quantified_VBN using_VBG a_DT Molecular_NP Dynamics_NPS PhosphorImager_NP ._SENT After_IN subtraction_NN of_IN background_NN lane_NN intensity_NN ,_, E1b-_NP or_CC MIEP-dependent_NP transcription_NN was_VBD normalized_VBN for_IN template_NN copy_NN number_NN and_CC gel_NN loading_NN as_RB described_VBD previously_RB ._SENT Luciferase_NN assays_NNS ._SENT |_SYM Monolayer_NP cultures_NNS of_IN HeLa_NP cells_NNS were_VBD coinfected_VBN with_IN 20_CD PFU_NN of_IN wt_JJ adenovirus_NN type_NN 5_CD or_CC a_DT test_NN strain/cell_NN ._SENT At_IN 4_CD hpi_NNS ,_, cell_NN lysates_NNS were_VBD prepared_VBN and_CC the_DT luciferase_NN activity_NN was_VBD assayed_VBN by_IN using_VBG the_DT luciferase_NN assay_NN system_NN with_IN reporter_NN lysis_NN buffer_NN (_( Promega_NP Corp._NP )_) according_VBG to_TO the_DT manufacturer_NN 's_POS protocol_NN ._SENT Light_JJ emission_NN was_VBD quantified_VBN on_IN an_DT FB12_NP luminometer_NN (_( Zylux_NP Corp._NP )_) ._SENT All_DT values_NNS were_VBD normalized_VBN to_TO extract_VB protein_NN concentrations_NNS (_( DC_NP protein_NN assay_NN ;_: Bio-Rad_NP Corp._NP )_) ._SENT DNase_NP I_NP footprinting_NN in_IN isolated_JJ nuclei_NNS ._SENT |_SYM HeLa_NP cells_NNS growing_VBG in_IN 150-mm_NP dishes_NNS were_VBD infected_VBN at_IN about_RB 60_CD %_NN confluence_NN with_IN 50_CD PFU_NN of_IN the_DT indicated_JJ virus/cell_NN ._SENT Only_RB CsCl-purified_JJ virus_NN was_VBD used_VBN for_IN in_IN vivo_JJ footprinting_NN ._SENT At_IN 4_CD to_TO 5_CD hpi_NNS ,_, monolayers_NNS were_VBD washed_VBN once_RB with_IN ice_NN cold_JJ Tris-buffered_JJ saline_NN (_( TBS_NP )_) and_CC then_RB removed_VBN from_IN the_DT surface_NN in_IN 5_CD ml_NN of_IN cold_JJ TBS/dish_NP ._SENT Nuclei_NNS for_IN DNase_NP I_NP digestion_NN were_VBD prepared_VBN as_IN described_VBN by_IN Cordingley_NP et_FW al._FW ._SENT The_DT cells_NNS were_VBD collected_VBN by_IN centrifugation_NN at_IN 800_CD x_NN g_NN for_IN 10_CD min_NN at_IN 4C_JJ and_CC suspended_VBN in_IN 5_CD ml_NN of_IN homogenization_NN buffer_NN (_( 0.01_CD M_NP Tris-HCl_NP [_SYM pH_NN 7.4_CD ]_SYM ,_, 0.015_CD M_NP NaCl_NP ,_, 0.06_CD M_NP KCl_NP ,_, 0.15_CD mM_NP spermine_NN ,_, 0.5_CD mM_NP spermidine_NN ,_, 0.01_CD M_NP EDTA_NP ,_, 0.1_CD mM_NP EGTA_NP ,_, 0.2_CD %_NN NP-40_NP ,_, 5_CD %_NN sucrose_NN ,_, 0.001_CD M_NP phenylmethylsulfonyl_NN fluoride_NN )_) per_IN dish_NN and_CC kept_VBD on_IN ice_NN for_IN 3_CD min_NN ._SENT The_DT cells_NNS were_VBD lysed_VBN with_IN a_DT few_JJ strokes_NNS of_IN a_DT Dounce_NP homogenizer_NN (_( 15_CD ml_NN )_) with_IN a_DT B_NP pestle_NN until_IN few_JJ intact_JJ cells_NNS remained_VBD ._SENT The_DT suspension_NN was_VBD carefully_RB layered_VBN over_IN 3.5_CD ml_NN of_IN homogenization_NN buffer_NN containing_VBG 10_CD %_NN sucrose_NN and_CC no_DT NP-40_NP ._SENT Nuclei_NNS were_VBD collected_VBN at_IN the_DT bottom_NN of_IN the_DT tube_NN by_IN centrifugation_NN for_IN 10_CD min_NN at_IN 1,200_CD x_NN g_NN at_IN 4C_JJ and_CC suspended_VBN in_IN an_DT equal_JJ volume_NN of_IN homogenization_NN buffer_NN ,_, but_CC with_IN 0.2_CD mM_NP EDTA_NP ,_, 0.2_CD mM_NP EGTA_NP ,_, and_CC no_DT NP-40_NP or_CC sucrose_NN (_( wash_NN buffer_NN )_) ._SENT The_DT nuclei_NNS were_VBD collected_VBN again_RB by_IN centrifugation_NN as_RB before_RB for_IN 3_CD min_NN and_CC suspended_VBN in_IN wash_NN buffer_NN at_IN a_DT concentration_NN of_IN about_RB 3.5_CD x_SYM 107_CD nuclei/ml_NN ._SENT Up_RB to_TO 32_CD U_NN of_IN DNase_NP I_NP (_( 1,000_CD U/ml_NP ;_: Promega)/ml_NP was_VBD added_VBN to_TO 0.5-ml_NN aliquots_NNS of_IN nuclei_NNS ,_, and_CC digestion_NN was_VBD initiated_VBN by_IN adding_VBG 5_CD mul_NN of_IN 0.2_CD M_NP CaCl2_NP ,_, 0.4_CD M_NP MgCl2_NP ._SENT Digestion_NN was_VBD for_IN 15_CD min_NN at_IN 4C_NP and_CC was_VBD terminated_VBN by_IN adding_VBG 0.05_CD ml_NN of_IN 1_CD M_NP Tris-HCl_NP (_( pH_NN 8.5_CD )_) ,_, 0.1_CD M_NP EDTA_NP ._SENT Digested_VBN nuclei_NNS were_VBD stored_VBN at_IN -80C_NN ._SENT For_IN DNA_NN extraction_NN ,_, the_DT nuclei_NNS were_VBD thawed_VBN and_CC diluted_VBN with_IN 5.25_CD ml_NN of_IN 6_CD M_NN guanidine-HCl_NN ,_, 0.1_CD M_NP sodium_NN acetate_NN ,_, pH_NN 5.5_CD ._SENT The_DT solution_NN was_VBD rocked_VBN gently_RB at_IN room_NN temperature_NN for_IN 1_CD h_NN ,_, and_CC the_DT solution_NN was_VBD carefully_RB layered_VBN under_IN 12.6_CD ml_NN of_IN absolute_JJ ethanol_NN in_IN a_DT 30-ml_JJ Corex_NP tube_NN ._SENT The_DT solution_NN was_VBD mixed_VBN gently_RB by_IN inversion_NN ,_, and_CC the_DT precipitate_NN was_VBD collected_VBN by_IN centrifugation_NN ._SENT The_DT pellet_NN was_VBD washed_VBN two_CD times_NNS with_IN 5_CD ml_NN of_IN absolute_JJ ethanol_NN ,_, dried_VBD briefly_RB ,_, and_CC suspended_VBD in_IN 0.9_CD ml_NN of_IN 0.1x_NP TE_NP (_( 1x_NP TE_NP is_VBZ 0.01_CD M_NP Tris-HCl_NP [_SYM pH_NN 8.0_CD ]_SYM ,_, 0.001_CD M_NP EDTA_NP )_) ._SENT After_IN at_IN least_JJS 16_CD h_NN at_IN 4C_NP ,_, the_DT suspension_NN was_VBD transferred_VBN to_TO a_DT clean_JJ centrifuge_NN tube_NN and_CC digested_VBN for_IN 1_CD h_NN at_IN 37C_JJ with_IN 100_CD U_NN of_IN HindIII/ml_NP to_TO reduce_VB the_DT viscosity_NN ._SENT Nucleic_JJ acid_NN was_VBD extracted_VBN three_CD times_NNS with_IN an_DT equal_JJ volume_NN of_IN TE-saturated_JJ phenol_NN and_CC once_RB with_IN chloroform-isoamyl_NN alcohol_NN (_( 24:1_CD )_) ,_, precipitated_VBD with_IN ethanol_NN ,_, suspended_VBN in_IN water_NN ,_, and_CC stored_VBD at_IN -20C_NN ._SENT Naked_JJ DNA_NN controls_NNS were_VBD prepared_VBN by_IN digesting_VBG purified_VBN DNA_NN from_IN infected_JJ cells_NNS with_IN 0.2_CD U_NN of_IN DNase_NP I/ml_NP for_IN 15_CD min_NN at_IN 4C_JJ ._SENT The_DT DNA_NN was_VBD extracted_VBN with_IN phenol_NN and_CC chloroform_NN ,_, precipitated_VBD ,_, and_CC suspended_VBD in_IN water_NN for_IN cycled_VBN primer_NN extension_NN ._SENT A_DT 50-pmol_JJ aliquot_NN of_IN primer_NN was_VBD 5'-end_NN labeled_VBN by_IN adding_VBG 50_CD pmol_NN of_IN [_SYM gamma-_JJ 32P]ATP_JJ (_( 6,000_CD Ci/mmol_NN )_) and_CC 25_CD U_NN of_IN T4_NP polynucleotide_NN kinase_NN in_IN 0.05_CD ml_NN ._SENT The_DT labeled_VBN primer_NN was_VBD isolated_VBN by_IN electrophoresis_NN in_IN a_DT denaturing_VBG 20_CD %_NN polyacrylamide_NN gel_NN ,_, or_CC a_DT 3_CD %_NN Biogel_NP (_( Qbiogene_NP ,_, Inc._NP )_) and_CC then_RB purified_VBN by_IN using_VBG MerMaid_NP spin_NN column_NN (_( Qbiogene_NP ,_, Inc._NP )_) chromatography_NN according_VBG to_TO the_DT manufacturer_NN 's_POS protocols_NNS ._SENT Twenty_CD cycles_NNS of_IN primer_NN extension_NN were_VBD performed_VBN using_VBG 25_CD U_NN of_IN Taq_NP DNA_NP polymerase_NN (_( Fisher_NP Scientific)/ml_NP in_IN buffer_NN B_NN with_IN 2_CD mM_NP MgCl2_NP ,_, 0.2_CD mM_NP deoxynucleoside_NN triphosphates_NNS ,_, approximately_RB 8_CD x_SYM 106_CD dpm_NN (_( about_RB 0.5_CD pmol_NN )_) of_IN labeled_VBN primer_NN ,_, and_CC DNA_NP from_IN about_RB 7_CD x_NN 106_CD nuclei_NNS ._SENT Extension_NN products_NNS were_VBD extracted_VBN once_RB with_IN chloroform-isoamyl_NN alcohol_NN ,_, precipitated_VBD ,_, and_CC suspended_VBN in_IN loading_VBG buffer_NN containing_VBG 80_CD %_NN formamide_NN for_IN 6-to-8_JJ %_NN denaturing_VBG polyacrylamide_NN gel_NN electrophoresis_NN ._SENT Dried_VBN gels_NNS were_VBD exposed_VBN to_TO Kodak_NP XAR-5_NP film_NN for_IN autoradiography_NN ._SENT Plots_NNS of_IN the_DT scans_NNS of_IN autoradiograms_NNS were_VBD generated_VBN using_VBG NIH_NP Image_NP ,_, version_NN 1.62_CD ._SENT Primers_NNS ._SENT |_SYM The_DT r-strand_NN primers_NNS were_VBD as_RB follows_VBZ :_: for_IN detection_NN of_IN wt_NP E1b_NP genomes_NNS ,_, adenovirus_NN type_NN 5_CD nt_NN 1817_CD to_TO 1794_CD ,_, 5'-GATGAGCCCCACAGAAACTCCAA-3_NP '_POS ;_: and_CC for_IN detection_NN of_IN genomes_NNS containing_VBG E1b-CAT_NP fusion_NN genes_NNS ,_, 5'-GGCCGTAATATCCAGCTGAACG-3_NP '_POS ,_, from_IN a_DT position_NN 77_CD nt_NNS further_JJR 3_CD '_POS with_IN respect_NN to_TO the_DT E1b_NP promoter_NN ._SENT The_DT l-strand_NN primers_NNS were_VBD as_RB follows_VBZ :_: Ad_NN 5_CD nt_NN 1325_CD to_TO 1350_CD ,_, 5'-CGACATCACCTGTGTCTAGAGAATGC-3_NP '_POS ;_: and_CC for_IN detection_NN of_IN genomes_NNS containing_VBG GGT_NP ,_, 5'-GCAGTAGGTAGAACCCTTG-3_NP '_POS in_IN the_DT mouse_NN betamaj-globin_NN sequence_NN (_( nt_NN 5403_CD to_TO 5421_CD )_) ,_, from_IN a_DT position_NN 48_CD nt_NNS further_JJR 5_CD '_POS with_IN respect_NN to_TO the_DT E1b_NP promoter_NN ._SENT Activity_NN of_IN a_DT composite_JJ termination_NN sequence_NN ._SENT The_DT mouse_NN betamaj-globin_NN transcription_NN termination_NN sequence_NN (_( GGT_NP )_) inhibits_VBZ readthrough_JJ transcription_NN and_CC dramatically_RB reduces_VBZ early_JJ E1b_NP RNA_NP synthesis_NN when_WRB it_PP is_VBZ inserted_VBN into_IN exon_NN 2_CD of_IN the_DT E1a_NP coding_VBG region_NN ._SENT For_IN GGT_NP ,_, inactivation_NN of_IN the_DT poly(A)_JJ addition_NN signals_NNS ,_, which_WDT are_VBP required_VBN for_IN termination_NN of_IN transcription_NN in_IN exon_NN 2_CD ,_, relieves_VBZ the_DT inhibition_NN of_IN early_JJ E1b_NP gene_NN transcription_NN ._SENT Therefore_RB ,_, the_DT ability_NN of_IN GGT_NP to_TO terminate_VB upstream_JJ transcription_NN is_VBZ necessary_JJ for_IN inhibition_NN of_IN downstream_JJ gene_NN transcription_NN ._SENT However_RB ,_, the_DT GGT_NP element_NN is_VBZ 1,560_CD bp_NN in_IN length_NN ,_, and_CC some_DT other_JJ intrinsic_JJ property_NN of_IN the_DT sequence_NN might_MD also_RB be_VB necessary_JJ ,_, but_CC not_RB sufficient_JJ ,_, for_IN inhibition_NN of_IN downstream_JJ promoter_NN function_NN by_IN the_DT exon_NN 2_CD insertions_NNS ._SENT In_IN fact_NN ,_, E1a_NP exon_NN 1_CD insertions_NNS of_IN either_DT wt_NN or_CC mutated_VBD GGT_NP prevent_VB readthrough_NN and_CC inhibit_VB downstream_JJ gene_NN transcription_NN (_( ;_: L._NP F._NP Maxfield_NP and_CC D._NP J._NP Spector_NP ,_, unpublished_JJ data_NNS )_) ._SENT Since_IN transcription_NN termination_NN of_IN GGT_NP is_VBZ expected_VBN to_TO be_VB poly(A)_JJ site_NN dependent_NN ,_, another_DT activity_NN of_IN GGT_NP aside_RB from_IN termination_NN of_IN transcription_NN also_RB might_MD affect_VB downstream_JJ promoter_NN activity_NN ._SENT To_TO address_VB these_DT issues_NNS ,_, we_PP designed_VBD another_DT candidate_NN termination_NN sequence_NN ._SENT pAGaT_NN was_VBD constructed_VBN by_IN deleting_VBG all_DT but_CC the_DT 5_CD '_POS 350_CD bp_NN of_IN GGT_NP ,_, essentially_RB retaining_VBG only_RB the_DT 3_CD '_POS part_NN of_IN the_DT globin_NN gene_NN exon_NN 3_CD that_WDT includes_VBZ the_DT poly(A)_JJ sites_NNS (_( pA_NP )_) ,_, and_CC joining_VBG it_PP to_TO a_DT 35-bp_JJ transcription_NN termination_NN sequence_NN from_IN the_DT human_JJ gastrin_NN gene_NN (_( GaT_NP )_) ._SENT The_DT gastrin_NN element_NN by_IN itself_PP was_VBD incapable_JJ of_IN terminating_VBG transcription_NN in_IN the_DT context_NN of_IN the_DT virus_NN (_( D._NP J._NP Spector_NP ,_, unpublished_JJ data_NNS )_) ._SENT From_IN here_RB on_RB ,_, the_DT hybrid_JJ element_NN will_MD be_VB referred_VBN to_TO as_IN CT_NP ,_, or_CC composite_JJ terminator_NN ._SENT To_TO test_VB both_CC the_DT termination_NN properties_NNS of_IN CT_NP and_CC its_PP$ possible_JJ effect_NN on_IN downstream_JJ gene_NN transcription_NN ,_, a_DT series_NN of_IN four_CD adenovirus_NN strains_NNS was_VBD constructed_VBN ._SENT Two_CD strains_NNS contained_VBD a_DT copy_NN of_IN CT_NP in_IN the_DT first_JJ (_( sub2022_JJ )_) or_CC second_JJ (_( sub2024_JJ )_) exon_NN of_IN E1a_NP and_CC a_DT luciferase_NN reporter_NN gene_NN in_IN place_NN of_IN the_DT E1b_NP coding_VBG sequences_NNS (_( E1b-Luc_NP )_) ._SENT Two_CD matching_JJ strains_NNS (_( sub2023_NN and_CC sub2025_NN )_) were_VBD constructed_VBN with_IN base_JJ substitution_NN mutations_NNS in_IN the_DT poly(A)_JJ signal_NN of_IN the_DT pA_NN segment_NN of_IN CT_NP (_( mCT_NN )_) ._SENT These_DT mutations_NNS relieve_VB termination_NN by_IN GGT_NP ._SENT To_TO compare_VB the_DT activity_NN of_IN CT_NP with_IN that_DT of_IN GGT_NP ,_, two_CD more_JJR strains_NNS (_( sub2028_NN and_CC sub2029_NN )_) were_VBD constructed_VBN with_IN GGT_NP or_CC inactivated_VBD GGT_NP inserted_VBD in_IN the_DT second_JJ exon_NN of_IN E1a_NP and_CC a_DT luciferase_NN gene_NN in_IN place_NN of_IN the_DT E1b_NP coding_VBG region_NN ._SENT Finally_RB ,_, control_NN strain_NN sub2100_NN contained_VBD the_DT E1b-Luc_NP gene_NN but_CC no_DT termination_NN sequence_NN insertion_NN ._SENT A_DT nonsense_JJ mutation_NN in_IN the_DT E1a_NP coding_VBG region_NN of_IN each_DT strain_NN eliminated_VBD the_DT possibility_NN that_IN functional_JJ E1a_NP proteins_NNS might_MD be_VB made_VBN from_IN some_DT strains_NNS but_CC not_RB others_NNS ._SENT The_DT dose_NN of_IN E1a_NP was_VBD controlled_VBN in_IN each_DT infection_NN by_IN complementation_NN (_( see_VB below_IN )_) ._SENT E1a_NN activation_NN of_IN the_DT E1b_NP promoter_NN was_VBD obtained_VBN in_IN the_DT presence_NN or_CC absence_NN of_IN readthrough_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Downstream_JJ gene_NN expression_NN was_VBD assayed_VBN by_IN two_CD methods_NNS ._SENT First_RB ,_, luciferase_NN activity_NN was_VBD determined_VBN after_IN infection_NN of_IN HeLa_NP cells_NNS or_CC 293_CD cells_NNS with_IN the_DT different_JJ recombinant_JJ viruses_NNS ._SENT In_IN HeLa_NP cells_NNS ,_, E1a_NP and_CC E1b_NP proteins_NNS were_VBD provided_VBN in_IN trans_NNS by_IN coinfection_NN with_IN wt_NN virus_NN ._SENT E1a_NP and_CC E1b_NP proteins_NNS are_VBP constitutively_RB expressed_VBN in_IN 293_CD cells_NNS ._SENT Accordingly_RB ,_, any_DT defect_NN in_IN E1b-Luc_NP expression_NN conferred_VBD by_IN the_DT CT_NP or_CC GGT_NP insertion_NN resulted_VBD from_IN a_DT cis-acting_JJ mechanism_NN ._SENT Second_RB ,_, steady-state_NN levels_NNS of_IN cytoplasmic_JJ E1b-Luc_NP RNA_NP in_IN infected_JJ HeLa_NP cells_NNS were_VBD measured_VBN by_IN hybridization_NN and_CC protection_NN from_IN S1_NP nuclease_NN digestion_NN ._SENT Again_RB ,_, E1a_NP and_CC E1b_NP proteins_NNS were_VBD provided_VBN in_IN trans_NNS by_IN coinfection_NN with_IN wt_NN virus_NN ._SENT Early_JJ RNA_NP from_IN the_DT adenovirus_NN E3_NP gene_NN was_VBD used_VBN as_IN an_DT internal_JJ control_NN because_IN early_JJ E3_NP transcription_NN is_VBZ not_RB affected_VBN by_IN termination_NN sequence_NN insertions_NNS in_IN E1_NP ._SENT By_IN either_DT assay_NN ,_, insertion_NN of_IN CT_NP or_CC GGT_NP in_IN exon_NN 2_CD of_IN the_DT E1a_NP gene_NN reduced_VBN E1b_NP expression_NN in_IN a_DT poly(A)_JJ site-dependent_NN manner_NN ._SENT The_DT inhibition_NN of_IN E1b_NP expression_NN by_IN CT_NP was_VBD not_RB as_RB efficient_JJ as_IN that_DT by_IN GGT_NP ._SENT When_WRB CT_NP was_VBD inserted_VBN into_IN the_DT first_JJ exon_NN of_IN the_DT E1a_NP gene_NN ,_, E1b_NP gene_NN expression_NN was_VBD reduced_VBN more_RBR dramatically_RB than_IN in_IN the_DT strains_NNS with_IN exon_NN 2_CD insertions_NNS ._SENT The_DT luciferase_NN expression_NN was_VBD near_IN background_NN ,_, and_CC mRNA_NN levels_NNS were_VBD indistinguishable_JJ from_IN the_DT background_NN ._SENT In_IN this_DT location_NN ,_, inhibition_NN of_IN E1b_NP gene_NN expression_NN by_IN the_DT exon_NN 1_CD insertion_NN was_VBD poly(A)_JJ site_NN independent_JJ ,_, a_DT result_NN also_RB obtained_VBN with_IN GGT_NP (_( data_NN not_RB shown_VBN )_) ._SENT To_TO determine_VB whether_IN inhibition_NN of_IN downstream_JJ gene_NN expression_NN was_VBD associated_VBN with_IN a_DT block_NN in_IN readthrough_JJ transcription_NN in_IN these_DT strains_NNS ,_, steady-state_NN levels_NNS of_IN readthrough_NP E1a_NP RNA_NP were_VBD measured_VBN by_IN hybridization-nuclease_NN protection_NN ,_, using_VBG a_DT probe_NN from_IN the_DT E1b_NP promoter_NN region_NN ._SENT This_DT probe_NN also_RB detected_VBD abundant_JJ wt_JJ E1a_NP mRNAs_NNS from_IN the_DT complementing_VBG strain_NN ._SENT Readthrough_NP transcripts_NNS were_VBD detected_VBN from_IN the_DT control_NN strain_NN sub2100_NN and_CC from_IN strains_NNS sub2025_NN and_CC sub2029_NN with_IN exon_NN 2_CD insertions_NNS of_IN termination_NN sequences_NNS with_IN inactivated_VBN poly(A)_NN sites_NNS ._SENT However_RB ,_, readthrough_NN transcripts_NNS did_VBD not_RB accumulate_VB to_TO detectable_JJ levels_NNS from_IN the_DT exon_NN 1_CD insertion_NN strains_NNS ,_, sub2022_NN and_CC sub2023_NN ,_, or_CC from_IN strains_NNS sub2024_NN and_CC sub2028_NN with_IN wt_JJ termination_NN sequence_NN insertions_NNS in_IN exon_NN 2_CD ._SENT Lack_NN of_IN readthrough_NN transcripts_NNS always_RB was_VBD accompanied_VBN by_IN reduced_VBN expression_NN of_IN the_DT E1b-Luc_NP gene_NN ._SENT As_IN well_RB ,_, detectable_JJ readthrough_NN transcription_NN always_RB was_VBD associated_VBN with_IN higher_JJR levels_NNS of_IN E1b-Luc_NP expression_NN ._SENT These_DT data_NNS show_VBP that_IN CT_NP had_VBD transcription_NN termination_NN and_CC downstream_JJ gene-inhibition_NN activities_NNS similar_JJ to_TO those_DT of_IN GGT_NP ,_, although_IN CT_NP was_VBD probably_RB a_DT less_RBR potent_JJ terminator_NN in_IN the_DT virus_NN ._SENT Therefore_RB ,_, the_DT ability_NN to_TO inhibit_VB downstream_JJ promoter_NN function_NN was_VBD not_RB unique_JJ to_TO GGT_NP ._SENT Rather_RB ,_, the_DT data_NNS strongly_RB support_VBP the_DT hypothesis_NN that_IN the_DT ability_NN of_IN sequence_NN elements_NNS to_TO prevent_VB readthrough_JJ transcription_NN from_IN E1a_NP is_VBZ both_DT necessary_JJ and_CC sufficient_JJ for_IN inhibition_NN of_IN downstream_JJ E1b_NP gene_NN expression_NN ._SENT Effect_NN of_IN readthrough_JJ transcription_NN on_IN early_JJ activity_NN of_IN the_DT MLP_NP ._SENT |_SYM If_IN readthrough_NN activation_NN originates_VBZ from_IN a_DT global_JJ property_NN of_IN the_DT early_JJ viral_JJ template_NN ,_, such_JJ as_IN transcription-driven_JJ remodeling_NN ,_, one_PP might_MD expect_VB that_IN the_DT early_JJ function_NN of_IN other_JJ viral_JJ promoters_NNS would_MD be_VB affected_VBN ._SENT Insertion_NN of_IN GGT_NP in_IN E1a_NP ,_, which_WDT is_VBZ in_IN the_DT left_VBN half_NN of_IN the_DT genome_NN ,_, does_VBZ not_RB affect_VB the_DT transcription_NN of_IN the_DT E3_NP promoter_NN in_IN the_DT right_JJ half_NN of_IN the_DT genome_NN ._SENT However_RB ,_, leftward_JJ readthrough_JJ transcription_NN from_IN the_DT strong_JJ E4_NP promoter_NN at_IN the_DT right_JJ end_NN of_IN the_DT genome_NN could_MD conceivably_RB produce_VB any_DT global_JJ template_NN changes_NNS required_VBN for_IN activation_NN of_IN the_DT E2_NP and_CC E3_NP transcription_NN units_NNS ._SENT Any_DT distal_JJ effects_NNS of_IN transcriptional_JJ readthrough_NN from_IN E1a_NP might_MD only_RB be_VB manifest_JJ in_IN the_DT left_VBN half_NN of_IN the_DT genome_NN ._SENT The_DT MLP_NP ,_, whose_WP$ early_JJ activity_NN is_VBZ comparable_JJ to_TO that_DT of_IN the_DT other_JJ early_JJ promoters_NNS ,_, is_VBZ the_DT next_JJ promoter_NN downstream_JJ of_IN E1b_NP that_WDT is_VBZ active_JJ early_RB ._SENT Accordingly_RB ,_, an_DT experiment_NN was_VBD performed_VBN to_TO determine_VB whether_IN the_DT activity_NN of_IN the_DT MLP_NP was_VBD affected_VBN by_IN GGT_NP insertions_NNS in_IN E1a_NP ._SENT Strain_NN in2011_NN has_VBZ an_DT insertion_NN of_IN GGT_NP in_IN exon_NN 1_CD of_IN E1a_NP ,_, and_CC sub2040_NN has_VBZ an_DT exon_NN 2_CD insertion_NN ._SENT Both_CC of_IN these_DT strains_NNS fail_VBP to_TO accumulate_VB readthrough_NN transcripts_NNS and_CC produce_VB dramatically_RB reduced_VBN amounts_NNS of_IN early_JJ E1b_NP RNA_NP ._SENT sub2047_JJ is_VBZ identical_JJ to_TO sub2040_NN ,_, except_IN that_WDT the_DT former_JJ has_VBZ an_DT inactivated_VBN GGT_NP sequence_NN ._SENT dl2004_NN and_CC sub2046_NN are_VBP the_DT parental_JJ strains_NNS of_IN in2011_JJ and_CC sub2040_JJ ,_, respectively_RB ,_, without_IN the_DT GGT_NP insertions_NNS ._SENT All_DT of_IN these_DT strains_NNS have_VBP defects_NNS in_IN the_DT E1a_NP and_CC E1b_NP coding_VBG regions_NNS ,_, and_CC so_RB infections_NNS were_VBD performed_VBN in_IN 293_CD cells_NNS to_TO provide_VB the_DT early_JJ E1_JJ proteins_NNS in_IN trans_NNS ._SENT The_DT results_NNS indicate_VBP that_IN the_DT ratio_NN of_IN MLP_NP to_TO E3_NP RNA_NP was_VBD the_DT same_JJ for_IN each_DT strain_NN ._SENT Therefore_RB ,_, the_DT effect_NN of_IN transcription_NN termination_NN in_IN E1a_NP did_VBD not_RB extend_VB to_TO the_DT MLP_NP ,_, the_DT next_JJ promoter_NN downstream_JJ of_IN E1b_NP ._SENT The_DT relationship_NN between_IN transcription_NN termination_NN and_CC the_DT activity_NN of_IN the_DT E1a_NP enhancer_NN on_IN E1b_NP early_JJ gene_NN expression_NN ._SENT |_SYM The_DT E1a_NP enhancer_NN mediates_VBZ two_CD kinds_NNS of_IN activities_NNS ._SENT One_PP regulates_VBZ E1a_NP gene_NN expression_NN ,_, whereas_IN the_DT second_NN activates_VBZ the_DT transcription_NN of_IN the_DT other_JJ early_JJ viral_JJ genes_NNS in_IN cis_NNS ._SENT One_CD possible_JJ role_NN for_IN readthrough_NN activation_NN is_VBZ to_TO facilitate_VB a_DT functional_JJ interaction_NN between_IN the_DT E1a_NP enhancer_NN and_CC the_DT E1b_NP promoter_NN ._SENT If_IN so_RB ,_, then_RB mutations_NNS that_WDT interfere_VBP with_IN both_DT readthrough_NN and_CC enhancer_NN function_NN might_MD be_VB expected_VBN to_TO exhibit_VB epistasis_NN ,_, that_WDT is_VBZ ,_, the_DT reduction_NN in_IN expression_NN caused_VBN by_IN one_CD mutation_NN should_MD mask_VB any_DT additional_JJ phenotype_NN from_IN the_DT second_NN in_IN double_JJ mutant_JJ strains_NNS ._SENT To_TO evaluate_VB this_DT possibility_NN ,_, early_JJ gene_NN expression_NN was_VBD assayed_VBN from_IN three_CD recombinant_JJ viruses_NNS ._SENT Strain_NN dl340/112-2_NN (_( Enh-_NP RT+_NP )_) has_VBZ a_DT deletion_NN in_IN the_DT enhancer-encapsidation_NN region_NN of_IN the_DT genome_NN (_( nt_NN positions_NNS 195_CD to_TO 357_CD )_) that_WDT removes_VBZ both_CC the_DT E1a-specific_JJ enhancer_NN components_NNS (_( element_NN I_CD )_) and_CC the_DT enhancer_NN that_WDT governs_VBZ all_DT early_JJ viral_JJ transcription_NN in_IN cis_NNS (_( element_NN II_CD )_) ._SENT Strain_NN in2011_NN (_( Enh+_NP RT-_NP )_) has_VBZ a_DT GGT_NP insertion_NN that_WDT prevents_VBZ readthrough_NN ._SENT Strain_NN in2011-2_NN (_( Enh-_NP RT-_NP )_) has_VBZ both_DT mutations_NNS ._SENT The_DT control_NN strain_NN dl343-112_NN (_( RT+_NP Enh+_NP )_) has_VBZ the_DT same_JJ E1b_NP and_CC E3_NP genetic_JJ backgrounds_NNS as_IN the_DT other_JJ strains_NNS ._SENT HeLa_NP cells_NNS were_VBD coinfected_VBN with_IN wt_JJ adenovirus_NN type_NN 5_CD and_CC a_DT recombinant_JJ virus_NN ,_, and_CC early_RB E1b_NP and_CC E3_NP RNA_NP were_VBD assayed_VBN at_IN 4.25_CD hpi_NNS ._SENT Single_JJ infections_NNS were_VBD performed_VBN with_IN dl2004_NN and_CC wt_NN adenovirus_NN type_NN 5_CD to_TO provide_VB standards_NNS for_IN the_DT RNAs_NP made_VBD from_IN the_DT test_NN strain_NN and_CC complementing_VBG strain_NN ,_, respectively_RB ._SENT After_IN subtraction_NN of_IN the_DT background_NN (_( E1b_NP wt_NP )_) ,_, each_DT mutation_NN alone_RB resulted_VBD in_IN about_IN a_DT 10-fold_NN decrease_NN in_IN E1b_NP RNA_NP in_IN cis_NNS ,_, whereas_IN the_DT double_JJ mutation_NN produced_VBD a_DT 50-fold_NN decrease_NN ._SENT In_IN a_DT second_JJ experiment_NN ,_, each_DT single_JJ mutant_NN was_VBD down_RB 15-_CD to_TO 20-fold_NN and_CC the_DT double_JJ mutant_NN was_VBD down_RB about_RB 300-fold_JJ ._SENT As_IN expected_VBN ,_, enhancer_NN mutants_NNS also_RB made_VBD less_RBR E3_NP RNA_NP ._SENT These_DT data_NNS provided_VBD no_DT evidence_NN for_IN an_DT epistatic_JJ interaction_NN between_IN the_DT two_CD kinds_NNS of_IN mutations_NNS ._SENT Therefore_RB ,_, transcription_NN termination_NN probably_RB did_VBD not_RB affect_VB substantially_RB any_DT functional_JJ interaction_NN between_IN the_DT E1a_NP enhancer_NN and_CC the_DT E1b_NP promoter_NN ._SENT Furthermore_RB ,_, as_IN observed_VBN in_IN a_DT similar_JJ analysis_NN of_IN double_JJ mutants_NNS with_IN defects_NNS in_IN readthrough_NN and_CC the_DT E1b_NP promoter_NN ,_, the_DT data_NNS show_VBP that_IN readthrough_NP effectively_RB activated_VBD a_DT highly_RB weakened_VBN E1b_NP promoter_NN (_( compare_VB Enh-_NP RT-_NP with_IN Enh-_NP RT+_NP )_) ._SENT Suppression_NN of_IN the_DT requirement_NN for_IN readthrough_JJ transcription_NN by_IN a_DT strong_JJ downstream_JJ enhancer-promoter_NN ._SENT |_SYM The_DT results_NNS of_IN the_DT experiments_NNS above_RB are_VBP consistent_JJ with_IN the_DT notion_NN that_IN activation_NN requires_VBZ only_RB an_DT upstream_JJ source_NN of_IN readthrough_JJ transcription_NN and_CC the_DT downstream_JJ E1b_NP promoter_NN ._SENT That_DT is_VBZ ,_, the_DT mechanism_NN of_IN action_NN depends_VBZ only_RB on_IN an_DT interaction_NN between_IN the_DT invading_VBG RNA_NP polymerase_NN elongation_NN complex_NN and_CC the_DT E1b_NP promoter_NN ._SENT One_PP might_MD expect_VB such_PDT a_DT localized_JJ interaction_NN to_TO stimulate_VB the_DT activity_NN of_IN weak_JJ promoters_NNS but_CC to_TO be_VB unnecessary_JJ for_IN strong_JJ downstream_JJ promoters_NNS ._SENT If_IN so_RB ,_, then_RB the_DT requirement_NN should_MD be_VB relieved_VBN ,_, or_CC suppressed_VBD ,_, by_IN substituting_VBG a_DT strong_JJ promoter_NN for_IN E1b_NP ._SENT Accordingly_RB ,_, the_DT E1b_NP promoter_NN was_VBD replaced_VBN with_IN the_DT human_JJ cytomegalovirus_NN MIEP_NP in_IN recombinant_JJ adenoviruses_NNS with_IN various_JJ termination_NN sequence_NN insertions_NNS ._SENT Strains_NNS sub2020_NN and_CC sub2026_NN have_VBP CT_NP insertions_NNS in_IN the_DT first_JJ and_CC second_JJ exons_NNS of_IN E1a_NP ,_, respectively_RB ._SENT sub2021_JJ and_CC sub2027_JJ are_VBP versions_NNS of_IN these_DT two_CD strains_NNS with_IN inactivated_VBN CT_NP (_( mCT_NN )_) ._SENT sub2030_JJ and_CC sub2031_JJ have_VBP the_DT wt_NN and_CC inactivated_VBN forms_NNS of_IN GGT_NP ,_, respectively_RB ,_, inserted_VBN into_IN the_DT second_JJ exon_NN of_IN E1a_NP ._SENT MIEP-Luc_NP gene_NN expression_NN was_VBD assayed_VBN either_RB by_IN measuring_VBG luciferase_NN activity_NN or_CC by_IN determining_VBG steady-state_NN levels_NNS of_IN cytoplasmic_JJ MIEP-Luc_NP RNA_NP in_IN HeLa_NP cells_NNS coinfected_VBN with_IN wt_NN virus_NN as_RB described_VBD above_IN ._SENT The_DT data_NNS indicate_VBP that_IN MIEP_NP mediated_VBD a_DT high_JJ level_NN of_IN luciferase_NN expression_NN or_CC RNA_NP synthesis_NN regardless_RB of_IN whether_IN the_DT termination_NN element_NN was_VBD wt_JJ or_CC mutant_JJ ._SENT Assays_NNS for_IN readthrough_NP RNA_NP yielded_VBD the_DT expected_VBN result_NN :_: readthrough_NP was_VBD observed_VBN only_RB when_WRB an_DT exon_NN 2_CD termination_NN element_NN was_VBD inactivated_VBN ._SENT Because_IN sub2030_NN and_CC sub2031_NN grew_VBD poorly_RB and_CC produced_VBN low-titer_NN stocks_NNS ,_, a_DT relatively_RB large_JJ volume_NN of_IN lysate_NNS was_VBD required_VBN to_TO achieve_VB the_DT desired_VBN multiplicity_NN of_IN infection_NN ._SENT Under_IN these_DT conditions_NNS ,_, a_DT general_JJ inhibition_NN of_IN viral_JJ gene_NN expression_NN was_VBD observed_VBN ,_, as_RB reflected_VBN in_IN the_DT low_JJ levels_NNS of_IN viral_JJ RNA_NP in_IN the_DT corresponding_JJ samples_NNS ._SENT These_DT results_NNS show_VBP that_IN readthrough_JJ and_CC downstream_JJ gene_NN expression_NN were_VBD completely_RB uncoupled_VBN when_WRB the_DT E1b_NP promoter_NN was_VBD replaced_VBN by_IN MIEP_NP ._SENT That_DT is_VBZ ,_, MIEP_NP functioned_VBD at_IN a_DT high_JJ level_NN regardless_RB of_IN whether_IN readthrough_NN was_VBD present_JJ or_CC absent_JJ ._SENT Therefore_RB ,_, substitution_NN of_IN the_DT relatively_RB weak_JJ E1b_NP promoter_NN with_IN a_DT strong_JJ downstream_JJ promoter_NN relieved_VBN or_CC suppressed_VBN the_DT requirement_NN for_IN readthrough_JJ activation_NN in_IN this_DT region_NN of_IN the_DT viral_JJ genome_NN ._SENT This_DT result_NN further_RBR supported_VBD the_DT notion_NN that_IN readthrough_JJ acts_NNS through_IN a_DT local_JJ interaction_NN at_IN the_DT site_NN of_IN the_DT E1b_NP promoter_NN ._SENT Effect_NN of_IN readthrough_NN on_IN E1b_NP promoter_NN structure_NN ._SENT |_SYM To_TO examine_VB the_DT effect_NN of_IN readthrough_NN on_IN DNA-protein_NP interactions_NNS at_IN the_DT E1b_NP promoter_NN in_IN infected_JJ cells_NNS ,_, DNase_NP I_NP footprinting_NN was_VBD performed_VBN ._SENT Proteins_NNS bound_VBN to_TO DNA_NP can_MD protect_VB the_DT DNA_NN from_IN DNase_NP I_NP digestion_NN or_CC distort_VB the_DT double_JJ helix_NN to_TO produce_VB hypersensitive_JJ sites_NNS of_IN digestion_NN ._SENT At_IN high_JJ multiplicities_NNS of_IN infection_NN and_CC a_DT corresponding_JJ high_JJ copy_NN number_NN of_IN early_JJ templates_NNS per_IN nucleus_NN ,_, only_RB a_DT small_JJ fraction_NN of_IN templates_NNS may_MD be_VB engaged_VBN in_IN promoter_NN complex_JJ formation_NN at_IN a_DT given_VBN gene_NN at_IN any_DT particular_JJ time_NN ._SENT Under_IN these_DT conditions_NNS ,_, regions_NNS protected_VBN from_IN DNase_NP I_NP digestion_NN may_MD be_VB difficult_JJ to_TO observe_VB against_IN a_DT high_JJ background_NN of_IN viral_JJ DNA_NN molecules_NNS with_IN a_DT different_JJ structure_NN ._SENT However_RB ,_, hypersensitive_JJ sites_NNS will_MD appear_VB as_IN enhanced_JJ signals_NNS ._SENT Viral_JJ infections_NNS at_IN low_JJ multiplicities_NNS failed_VBD to_TO produce_VB detectable_JJ signals_NNS after_IN DNase_NP I_NP digestion_NN of_IN isolated_JJ nuclei_NNS ,_, so_IN high-multiplicity_NN conditions_NNS were_VBD used_VBN for_IN the_DT analysis_NN presented_VBD here_RB ._SENT Hypersensitivity_NN of_IN positions_NNS in_IN viral_JJ DNA_NN digested_VBN in_IN infected_JJ cell_NN nuclei_NNS was_VBD scored_VBN as_IN the_DT reproducible_JJ appearance_NN of_IN bands_NNS that_WDT were_VBD not_RB observed_VBN either_RB with_IN undigested_JJ nuclei_NNS or_CC with_IN DNA_NN purified_VBN from_IN infected_JJ cell_NN nuclei_NNS before_IN digestion_NN ._SENT A_DT very_RB conservative_JJ approach_NN was_VBD adopted_VBN ._SENT A_DT band_NN was_VBD considered_VBN indicative_JJ of_IN hypersensitivity_NN only_RB if_IN the_DT relative_JJ difference_NN from_IN the_DT surrounding_VBG background_NN in_IN the_DT same_JJ lane_NN was_VBD reprod_VBN 